FutureCure Health obtains Rs 30 crore in series A funding

Advisor Limited, and other investors, the company said on Monday. The firm plans to use the funds for developing technologies for the diagnosis and treatment of chronic diseases like migraine, dizziness etc, for FDA approvals and for global expansion.

"FutureCure is manufacturing cutting-edge technologies to diagnose and treat chronic diseases like migraine, dizziness, etc. FutureCure plans to launch various technologies for migraine patients, including wearable neuromodulation and biofeedback devices. In addition, the digital therapeutics app will help identify the triggers using AI and help accomplish lifestyle changes," Futurecure Rajneesh Bhandari said in the statement.